DiNonA licences leukotuximab to 3SBio

DiNonA Inc. (Seoul, South Korea) granted 3SBio Inc. (Shenyang, China) exclusive rights to develop and commercialize DiNonA's leukotuximab in Taiwan and China, including Hong Kong and Macau, as well as...